Skip to main content

Articles

Page 5 of 57

  1. The triglyceride-glucose (TyG) index was significantly associated with insulin resistance (IR). Several studies have validated the effect of TyG index on cerebrovascular disease. However, the value of TyG inde...

    Authors: Weimin Cai, Jun Xu, Xiao Wu, Zhuoyan Chen, Liuwei Zeng, Xian Song, Yuan Zeng and Fujun Yu
    Citation: Cardiovascular Diabetology 2023 22:138
    Content type: Research Published on:

  2. Visceral obesity is associated with high cardiovascular events risk in type 2 diabetes mellitus (T2DM). Whether normal-weight visceral obesity will pose a higher atherosclerotic cardiovascular disease (ASCVD) ...

    Authors: Jia Zheng, Ye Hu, Hanwen Xu, Yu Lei, Jieji Zhang, Qidong Zheng, Li Li, Weiping Tu, Riqiu Chen, Qiongyao Guo, Xunxiong Zang, Qiaoying You, Zhiyong Xu, Qiang Zhou and Xiaohong Wu
    Citation: Cardiovascular Diabetology 2023 22:137
    Content type: Research Published on:

  3. Lower-extremity endovascular revascularization (LER) is often required for diabetic patients with chronic limb threatening ischemia (CLTI). During the post-revascularization period patients may unpredictably e...

    Authors: Elisabetta Nardella, Federico Biscetti, Maria Margherita Rando, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Enrica Rossini, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini and Andrea Flex
    Citation: Cardiovascular Diabetology 2023 22:136
    Content type: Research Published on:

  4. The association of incident cardiometabolic multimorbidity (CMM) with mortality risk is rarely studied, and neither are the durations of cardiometabolic diseases (CMDs). Whether the association patterns of CMD...

    Authors: Yuting Han, Yizhen Hu, Canqing Yu, Dianjianyi Sun, Yuanjie Pang, Pei Pei, Ling Yang, Yiping Chen, Huaidong Du, Jingchao Liu, Dan Schmidt, Daniel Avery, Junshi Chen, Zhengming Chen, Liming Li and Jun Lv
    Citation: Cardiovascular Diabetology 2023 22:135
    Content type: Research Published on:

  6. The triglyceride–glucose (TyG) index has been proposed as a potential predictor of adverse prognosis of cardiovascular diseases (CVDs). However, its prognostic value in patients with coronary heart disease (CH...

    Authors: Yahui Liu, Binbin Zhu, Weicen Zhou, Yao Du, Datun Qi, Chenxu Wang, Qianqian Cheng, You Zhang, Shan Wang and Chuanyu Gao
    Citation: Cardiovascular Diabetology 2023 22:133
    Content type: Research Published on:

  7. Stroke has been found to be highly correlated with the triglyceride-glucose (TyG) index. The relation between the TyG index changes and stroke, however, has seldom been reported, and current researches mention...

    Authors: Yaoling Wu, Yongbiao Yang, Jinsheng Zhang, Shuo Liu and Weiduan Zhuang
    Citation: Cardiovascular Diabetology 2023 22:132
    Content type: Research Published on:

  8. The triglyceride-glucose (TyG) index has been recognized as being an alternative cardiometabolic biomarker for insulin resistance associated with the development and prognosis of cardiovascular disease (CVD). ...

    Authors: Haixu Yu, Liyuan Tao, Yan-Guang Li, Lincheng Yang, Dan Liu, Yang Wang, Xiaoyan Hao, Honghai He, Ying Che, Peng Wang, Wei Zhao and Wei Gao
    Citation: Cardiovascular Diabetology 2023 22:130
    Content type: Research Published on:

  9. Patients with prediabetes or diabetes are at increased risk of developing cardiovascular disease and adverse outcomes. First-line coronary computed tomography angiography (CTA) followed by selective use of pos...

    Authors: Matias Mäenpää, Iida Kujala, Esa Harjulahti, Iida Stenström, Wail Nammas, Juhani Knuuti, Antti Saraste and Teemu Maaniitty
    Citation: Cardiovascular Diabetology 2023 22:129
    Content type: Research Published on:

  10. Glucagon is thought to increase heart rate and contractility by stimulating glucagon receptors and increasing 3′,5′-cyclic adenosine monophosphate (cAMP) production in the myocardium. This has been confirmed i...

    Authors: Ramón Aranda-Domene, Esteban Orenes-Piñero, José María Arribas-Leal, Sergio Canovas-Lopez and Jesús Hernández-Cascales
    Citation: Cardiovascular Diabetology 2023 22:128
    Content type: Research Published on:

  11. Authors: Vittoria Favero, Carmen Aresta, Chiara Parazzoli, Elisa Cairoli, Cristina Eller-Vainicher, Serena Palmieri, Antonio Stefano Salcuni, Maura Arosio, Luca Persani, Alfredo Scillitani, Valentina Morelli and Iacopo Chiodini
    Citation: Cardiovascular Diabetology 2023 22:127
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2023 22:102

  12. In clinical trials enrolling patients with type 2 diabetes (T2D) at high cardiovascular risk, many glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improved albuminuria status and possibly mitigated kidne...

    Authors: Meir Schechter, Cheli Melzer Cohen, Alisa Fishkin, Aliza Rozenberg, Ilan Yanuv, Dvora R. Sehtman-Shachar, Gabriel Chodick, Alice Clark, Trine J. Abrahamsen, Jack Lawson, Avraham Karasik and Ofri Mosenzon
    Citation: Cardiovascular Diabetology 2023 22:126
    Content type: Research Published on:

  13. The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis i...

    Authors: Qin Huang, Zeyu Liu, Minping Wei, Qing Huang, Jie Feng, Zunjing Liu and Jian Xia
    Citation: Cardiovascular Diabetology 2023 22:125
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:246

  14. Atrial fibrillation (AF) and heart failure (HF) frequently coexist because of their similar pathological basis. However, whether sodium-glucose cotransporter 2 inhibitor (SGLT2i), a novel class of anti-HF medi...

    Authors: Xiaolan Ouyang, Jiafu Wang, Qian Chen, Long Peng, Suhua Li and Xixiang Tang
    Citation: Cardiovascular Diabetology 2023 22:124
    Content type: Review Published on:

  15. In this review, we summarise new insights into diagnostic approaches and treatment strategies for coronary artery disease (CAD) in patients with diabetes mellitus (DM). Despite the improvements in therapy, the...

    Authors: Tobias Michiel Hommels, Renicus Suffridus Hermanides, Enrico Fabris and Elvin Kedhi
    Citation: Cardiovascular Diabetology 2023 22:123
    Content type: Review Published on:

  16. Diabetes mellitus, a group of metabolic disorders characterized by high levels of blood glucose caused by insulin defect or impairment, is a major risk factor for cardiovascular diseases and related mortality....

    Authors: Gaia Spinetti, Martina Mutoli, Simona Greco, Federica Riccio, Soumaya Ben-Aicha, Franziska Kenneweg, Amela Jusic, David de Gonzalo-Calvo, Anne Yaël Nossent, Susana Novella, Georgios Kararigas, Thomas Thum, Costanza Emanueli, Yvan Devaux and Fabio Martelli
    Citation: Cardiovascular Diabetology 2023 22:122
    Content type: Review Published on:

  17. Pericoronary adipose tissue (PCAT) density is a biomarker of vessel inflammation, which is supposed to be increased in patients with type 2 diabetes mellitus (T2DM). However, whether the coronary inflammation ...

    Authors: Meng-Meng Yu, Xin Zhao, Yin-Yin Chen, Xin-Wei Tao, Jun-Bo Ge, Hang Jin and Meng-Su Zeng
    Citation: Cardiovascular Diabetology 2023 22:121
    Content type: Research Published on:

  18. Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus (DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the clinical impact of DCB-based revascul...

    Authors: Ae-Young Her, Eun-Seok Shin, Sunwon Kim, Bitna Kim, Tae-Hyun Kim, Chang-Bae Sohn, Byung Joo Choi, Yongwhi Park, Jung Rae Cho and Young-Hoon Jeong
    Citation: Cardiovascular Diabetology 2023 22:120
    Content type: Research Published on:

  19. We assessed the impact of 24 months of treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on endothelial function in patients with type 2 diabetes as a sub-analysis of the PROTEC...

    Authors: Shinji Kishimoto, Yukihito Higashi, Takumi Imai, Kazuo Eguchi, Kazuo Fukumoto, Hirofumi Tomiyama, Koji Maemura, Atsushi Tanaka and Koichi Node
    Citation: Cardiovascular Diabetology 2023 22:119
    Content type: Research Published on:

  20. The triglyceride–glucose (TyG) index has been shown to be a new alternative measure for insulin resistance. However, no study has attempted to investigate the association of the TyG index with incident atrial ...

    Authors: Xiao Liu, Ayiguli Abudukeremu, Yuan Jiang, Zhengyu Cao, Maoxiong Wu, Jianyong Ma, Runlu Sun, Wanbing He, Zhiteng Chen, Yangxin Chen, Peng Yu, Wengen Zhu, Yuling Zhang and Jingfeng Wang
    Citation: Cardiovascular Diabetology 2023 22:118
    Content type: Research Published on:

  23. Few studies have assessed the correlation between coexisting mental disorders in participants with diabetes mellitus (DM) and the risk of heart failure (HF). Herein, we conducted a cohort study to determine th...

    Authors: Tae Kyung Yoo, Kyung-Do Han, Eun-Jung Rhee and Won-Young Lee
    Citation: Cardiovascular Diabetology 2023 22:115
    Content type: Research Published on:

  24. Metabolic abnormalities such as dyslipidemia, glucose and high blood pressure are common in diabetic patients. Visit-to-visit variabilities in these measures have been reported as potential residual cardiovasc...

    Authors: Subin Lim, Se Hwa Chung, Ju Hyeon Kim, Yong Hyun Kim, Eung Ju Kim and Hyung Joon Joo
    Citation: Cardiovascular Diabetology 2023 22:114
    Content type: Research Published on:

  25. Coronary microvascular dysfunction (CMD) is a strong determinant of prognosis in patients with chronic coronary syndrome (CCS). The triglyceride-glucose index (TyG index), an alternative method to evaluate ins...

    Authors: Wen Zhang, Lu Liu, Huiying Chen, Siqi Li, Minying Wan, Abdul-Quddus Mohammed, Bin Xu, Guoqing Yin, Xian Lv, Tingting Shi, Jassur Galip, Ayman A. Mohammed, Redhwan M. Mareai, Yawei Xu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:113
    Content type: Research Published on:

  26. Atherosclerosis is a common co-morbidity of type 2 diabetes mellitus. Monocyte recruitment by an activated endothelium and the pro-inflammatory activity of the resulting macrophages are critical components of ...

    Authors: Heng Yu, Hunter F. Douglas, Donald Wathieu, Ryan A. Braun, Christine Edomwande, Daniel J. Lightell Jr., Thaidan Pham, Natasha C. Klingenberg, Shelia Pugh Bishop, Damir B. Khismatullin and T. Cooper Woods
    Citation: Cardiovascular Diabetology 2023 22:112
    Content type: Research Published on:

  27. The triglyceride and glucose (TyG) index has been linked to various cardiovascular diseases. However, it's still unclear whether the TyG index is associated with arterial stiffness and coronary artery calcific...

    Authors: Fuwei Liu, Qin Ling, Shaofeng Xie, Yi Xu, Menglu Liu, Qingwen Hu, Jianyong Ma, Zhiwei Yan, Yan Gao, Yujie Zhao, Wengen Zhu, Peng Yu, Jun Luo and Xiao Liu
    Citation: Cardiovascular Diabetology 2023 22:111
    Content type: Methodology Published on:

  28. This study aimed to explore the association between the triglyceride glucose index (TyG) and the risk of in-hospital and one-year mortality in patients with chronic kidney disease (CKD) and cardiovascular dise...

    Authors: Zixiang Ye, Shuoyan An, Yanxiang Gao, Enmin Xie, Xuecheng Zhao, Ziyu Guo, Yike Li, Nan Shen and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:110
    Content type: Research Published on:

  29. This study compared the risks of cardiovascular morbidity and mortality between patients with type 2 diabetes (T2D) with and without microvascular diseases, and between matched patients with microvascular dise...

    Authors: Fu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, Chih-Cheng Hsu and Chii-Min Hwu
    Citation: Cardiovascular Diabetology 2023 22:109
    Content type: Research Published on:

  30. The FIDELIO-DKD and FIGARO-DKD randomized clinical trials (RCTs) showed finerenone, a novel non-steroidal mineralocorticoid receptor antagonist (MRA), reduced the risk of renal and cardiovascular events in pat...

    Authors: Peter Bramlage, Stefanie Lanzinger, Steffen Mühldorfer, Karsten Milek, Anton Gillessen, Roman Veith, Tobias Ohde, Thomas Danne, Reinhard W. Holl and Jochen Seufert
    Citation: Cardiovascular Diabetology 2023 22:108
    Content type: Research Published on:

  31. Endothelial injury caused by Type 2 diabetes mellitus (T2DM) is considered as a mainstay in the pathophysiology of diabetic vascular complications (DVCs). However, the molecular mechanism of T2DM-induced endot...

    Authors: Shilong You, Jiaqi Xu, Zeyu Yin, Boquan Wu, Pengbo Wang, Mingjun Hao, Cheng Cheng, Mengke Liu, Yuanhui Zhao, Pengyu Jia, Hongkun Jiang, Da Li, Liu Cao, Xingang Zhang, Ying Zhang, Yingxian Sun…
    Citation: Cardiovascular Diabetology 2023 22:107
    Content type: Research Published on:

  32. Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications i...

    Authors: Joonsang Yoo, Jimin Jeon, Minyoul Baik and Jinkwon Kim
    Citation: Cardiovascular Diabetology 2023 22:106
    Content type: Research Published on:

  33. We investigated, using population-based data, whether worse autonomic function, estimated from lower 24-hour heart rate variability (HRV), was associated with beta cell function, asse...

    Authors: Elisabetta Rinaldi, Frank CT van der Heide, Enzo Bonora, Maddalena Trombetta, Chiara Zusi, Abraham A Kroon, Miranda T Schram, Carla JH van der Kallen, Anke Wesselius, Riccardo Bonadonna, Andrea Mari, Casper G Schalkwijk, Marleen MJ van Greevenbroek and Coen DA Stehouwer
    Citation: Cardiovascular Diabetology 2023 22:105
    Content type: Research Published on:

  34. Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and that their circulating concentrations are independe...

    Authors: Damien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, Isabelle Simoneau, Laurent Demizieux, Patricia Passilly-Degrace, Benjamin Bouillet, Jean-Michel Petit, Alexia Rouland, Amandine Bataille, Laurence Duvillard and Bruno Vergès
    Citation: Cardiovascular Diabetology 2023 22:104
    Content type: Research Published on:

  35. Elevated serum uric acid (SUA) is regarded as a risk factor for the development of cardiovascular diseases. Triglyceride-glucose (TyG) index, a novel surrogate for insulin resistance (IR), has been proven to b...

    Authors: Zhenguo Wu, Cheng Cheng, Xiangfei Sun, Juan Wang, Dachuan Guo, Sha Chen, Yerui Zhang, Xiaoyu Liu, Li Liu, Cheng Zhang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2023 22:103
    Content type: Research Published on:

  36. Similarly to cortisol-secreting adrenal tumors, also non-functioning adrenal tumors (NFAT) may be associated with an increased cardiovascular risk. We assessed in NFAT patients: (i) the association between hyp...

    Authors: Vittoria Favero, Carmen Aresta, Chiara Parazzoli, Elisa Cairoli, Cristina Eller-Vainicher, Serena Palmieri, Antonio Stefano Salcuni, Maura Arosio, Luca Persani, Alfredo Scillitani, Valentina Morelli and Iacopo Chiodini
    Citation: Cardiovascular Diabetology 2023 22:102
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:127

  37. Sodium-glucose co-transporter-2 inhibitors are used in the treatment of diabetes but are also emerging as cardioprotective agents in heart diseases even in the absence of type 2 diabetes. In this paper, upon p...

    Authors: Julia Hoehlschen, Dominik Hofreither, Tamara Tomin and Ruth Birner-Gruenberger
    Citation: Cardiovascular Diabetology 2023 22:101
    Content type: Review Published on:

  38. Obesity is an independent risk factor for cardiovascular disease (CVD) in patients with type 2 diabetes (T2D). However, it is not known to what extent weight fluctuations might be associated with adverse outco...

    Authors: Giulia Ferrannini, Carol Pollock, Andrea Natali, Yshai Yavin, Kenneth W. Mahaffey and Ele Ferrannini
    Citation: Cardiovascular Diabetology 2023 22:100
    Content type: Research Published on:

  39. Abdominal ectopic fat deposition and excess visceral fat depots in obesity may be related to cardiovascular disease (CVD) as both are involved in the metabolic syndrome (MetS). The awareness of the link betwee...

    Authors: Yali Qu, Jing Liu, Jing Li, Sumin Shen, Xiaoyi Chen, Hehan Tang, Yuan Yuan, Chunchao Xia, Liping Deng, Guoyong Chen, Tianying Zheng, Jie Chen, Lisha Nie, Fang Yuan, Nanwei Tong, Liqing Peng…
    Citation: Cardiovascular Diabetology 2023 22:99
    Content type: Research Published on:

  40. Since the triglyceride glucose (TyG) index can reflect insulin resistance, it has been proven to be an efficient predictor of glycolipid-metabolism-related diseases. Therefore, this study aimed to investigate ...

    Authors: Qing Yang, Huichao Xu, Hongli Zhang, Yanying Li, Shuxiong Chen, Dongye He, Guangzhi Yang, Bo Ban, Mei Zhang and Fupeng Liu
    Citation: Cardiovascular Diabetology 2023 22:98
    Content type: Research Published on:

  41. Type 2 diabetes mellitus (T2DM) is a frequently observed complication in patients with heart failure with preserved ejection fraction (HFpEF). Although a characteristic finding in such patients is a decrease i...

    Authors: Yousuke Sugita, Katsuhiko Ito, Yui Yoshioka and Satoshi Sakai
    Citation: Cardiovascular Diabetology 2023 22:97
    Content type: Research Published on:

  42. Randomized controlled trials confirm that risks of residual cholesterol and residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid-lowering therapy. This study aims to inv...

    Authors: Ling Yang, Qing Yue, Fang Fang, Yinggen Zhang, Peipei Liu, Zihao Zhang, Guodong Wang, Shuohua Chen, Shouling Wu and Xiuhong Yang
    Citation: Cardiovascular Diabetology 2023 22:96
    Content type: Research Published on:

  43. Authors: Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki and Nobuya Inagaki
    Citation: Cardiovascular Diabetology 2023 22:95
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2023 22:62

  44. Women have a high risk of frailty independently of age and menopause state. Diabetes and hypertension increase the risk of frailty and cognitive impairment. Metformin has been employed in post-menopausal women...

    Authors: Pasquale Mone, Giuseppe Martinelli, Angela Lucariello, Anna Luisa Leo, Anna Marro, Stefano De Gennaro, Stefania Marzocco, Divina Moriello, Salvatore Frullone, Luigi Cobellis and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2023 22:94
    Content type: Research Published on:

  45. To investigate the difference of right ventricular (RV) structural and functional alteration in patients with diabetes mellitus (DM) with preserved left ventricular ejection fraction (LVEF), and the ventricula...

    Authors: Rui Shi, Zhi-Gang Yang, Ying-Kun Guo, Wen-Lei Qian, Yue Gao, Xue-Ming Li, Li Jiang, Hua-Yan Xu and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:93
    Content type: Research Published on:

  46. Acute kidney injury (AKI) can be caused by multiple factors/events, including acute coronary syndrome (ACS). Ceramides are involved in atherosclerosis progression, cardiovascular events, and renal damage. Almo...

    Authors: Lianjing Liang, Dongze Li, Rui Zeng, Haihong Zhang, Lin Lv, Wei Wei and Zhi Wan
    Citation: Cardiovascular Diabetology 2023 22:92
    Content type: Research Published on:

  47. Diabetes mellitus (DM) and atherosclerosis are multifactorial conditions and share a common inflammatory basis. Three-vessel disease (TVD) represents a major challenge for coronary intervention. Nonetheless, t...

    Authors: Lei Guo, Haichen Lv, Junjie Wang, Bo Zhang, Yifan Zhu, Xiaoyan Zhang, Hao Zhu, Xuchen Zhou and Yunlong Xia
    Citation: Cardiovascular Diabetology 2023 22:91
    Content type: Research Published on:

  48. The triglyceride-glucose (TyG) index, a simple measure of insulin resistance, is associated with intracranial atherosclerosis (ICAS) and stroke. In hypertensive populations, this association may be pronounced....

    Authors: Yongle Wang, Tingting Liu, Yanan Li, Kaili Zhang, Haimei Fan, Jing Ren, Juan Li, Yali Li, Xinyi Li, Xuemei Wu, Junhui Wang, Lixi Xue, Xiaolei Gao, Yuping Yan, Gaimei Li, Qingping Liu…
    Citation: Cardiovascular Diabetology 2023 22:90
    Content type: Research Published on:

  49. L-Arginine (L-Arg), is a semi-essential amino acid involved in the formation of nitric oxide. The functional relevance of L-Arg in diabetes mellitus has been evaluated both in animal models and in human subjec...

    Authors: Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, Stanislovas S. Jankauskas, Angelo Cioppa, Pasquale Mone, Luigi Salemme, Urna Kansakar, Tullio Tesorio, Valentina Trimarco and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2023 22:89
    Content type: Review Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:117

  50. An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arr...

    Authors: Petra Hrabalova, Romana Bohuslavova, Katerina Matejkova, Frantisek Papousek, David Sedmera, Pavel Abaffy, Frantisek Kolar and Gabriela Pavlinkova
    Citation: Cardiovascular Diabetology 2023 22:88
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    55 days submission to accept (Median)

    2022 Usage 
    2,116,496 downloads
    14,109 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840